Navigation Links
InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
Date:4/1/2008

ubstantial anti-viral effect at twice daily doses and an excellent safety and tolerability profile to date, ITMN-191 has the potential to be the best-in-class protease inhibitor for the treatment of patients with chronic hepatitis C virus infection," said Dan Welch, President and Chief Executive Officer of InterMune. "Strong viral kinetic performance of ITMN-191 was observed at total daily doses of less than or equal to only 600 mg, confirming its exceptional potency."

Mr. Welch continued, "With our partner Roche, we plan to initiate in this quarter a 14-day triple combination therapy trial with Pegasys(R) (pegylated interferon alfa-2a) and Copegus(R) (ribavirin). We also are exploring the combination of ITMN-191 with other small molecule compounds."

ITMN-191 Program Update - Clinical, Preclinical and Formulation Progress

InterMune also provided additional new information regarding the progress of the ITMN-191 program.

InterMune today reported that Clinical Trial Authorization (CTA) applications related to its 14-day triple combination study of ITMN-191 with Pegasys(R) (pegylated interferon alfa-2a) and Copegus(R) (ribavirin) were submitted to the relevant European regulatory authorities in March. InterMune expects the 14-day triple combination study to begin in the second quarter of 2008, assuming timely approvals by the relevant authorities.

Regarding future clinical development approaches, InterMune and its collaboration partner Roche also reported that the companies are actively working together to launch a development program that will investigate the combination of various small molecule compounds for the treatment of patients suffering from chronic HCV infection.

InterMune also announced today that a 13-week chronic toxicology study in monkeys has been successfully completed and that this study supports the intended longer duration of dosing of ITMN-191 planned in the Phase 2 clinical development program, to be conduc
'/>"/>

SOURCE InterMune, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. InterMune Announces Start of Phase 1b Trial of ITMN-191
2. InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191
3. Bionovo Announces Publication of the Paper Detailing the Mechanism of Action of Its Cancer Drug BZL101
4. Kingfisher Announces FDA 510(k) Clearance of Breakthrough KFH Energy for Chronic Pain Sufferers
5. Genaera Corporation Announces MSI-1436 Data Presented at Society of Neuroscience Meeting
6. Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial
7. Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
8. Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF
9. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
10. Nventa Announces Positive Interim Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial
11. Anacor Pharmaceuticals Announces Positive Results from Phase 2a Clinical Trial of AN2728 in Psoriasis Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... Apr. 24, 2015 Research and Markets ... the addition of the "Lab Accessories ... Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station) & End User (OEM/Biotechnology ... Forecast to 2020" report to their ... market is expected to reach $504.7 million ...
(Date:4/24/2015)... 2015  Novartis Pharmaceuticals Corporation (NPC) has been named the ... row on the annual DiversityInc Top 50 Companies for Diversity ... Companies for Diversity on April 23 at an awards ceremony ... ranked second on the DiversityInc Top 10 Companies for Recruitment ... Resource Groups list. David Epstein , ...
(Date:4/24/2015)... 24, 2015 Hi-Tech Pharmaceuticals refutes the ... the product of reliable scientific principles and methods ... for allegations of adulteration. The FDA is resting ... premise, or misguided hope, that Methylphenylethylamine is not ... contradicted by multiple other studies and cannot be ...
Breaking Medicine Technology:Global Lab Accessories Market Report 2015-2020 - Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station 2Global Lab Accessories Market Report 2015-2020 - Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station 3Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 2Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 3Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 4Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 2Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 3Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 4Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 5Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 6
... 30, 2012  PAREXEL International Corporation (NASDAQ: PRXL ... quarter ended March 31, 2012. For the ... revenue increased by 18.1% to $356.0 million compared with ... $3.8 million negative impact from foreign exchange on consolidated ...
... , Hajo Oltmanns to lead expansion of CPM,s ... a world-leading provider of scientific, technical and medical information products ... of Elsevier CPM Resource Center (CPM), a leader ... Hajo will lead the continued development and expansion of ...
Cached Medicine Technology:PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 2PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 3PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 4PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 5PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 6PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 7PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 8PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 9PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 10PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 11PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 12PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 13Elsevier Appoints New President of Elsevier CPM Resource Center 2
(Date:4/24/2015)... Integrative Therapeutics has introduced two new ... cognition. , A unique combination of herbs and ... Flavonoid Complex apart from other antioxidant supplements. This ... support antioxidation versus the use of single or ... extract, Resveratrol, Alpha-Glycosyl Isoquercitrin, and Coenzyme Q10 with ...
(Date:4/24/2015)... 2015 National Access Cannabis ... access to medical cannabis, is taking a leadership role ... advising patients. , NAC is the first to back ... $250,000 grant, NAC will be providing 300 healthcare professionals ... is to help Canadians gain safe and responsible access ...
(Date:4/24/2015)... (PRWEB) April 24, 2015 Eastern Star Masonic ... new Community Room on Sunday April 26th from 1:30-3:00 pm. ... to attend the ribbon cutting and grand opening of the ... will be on hand to offer tours to anyone who ... community. , The new community room will be available for ...
(Date:4/24/2015)... Recent research by the CareerBuilder and Economic Modeling ... assistants are among the top 10 health care occupations ... 2023. , Physical therapists are also listed among ... potential for expansion in the future. , During a ... therapists can offer great relief to patients suffering from ...
(Date:4/24/2015)... 24, 2015 A group of Southern Americans ... with a group of young Chinese for two weeks from ... the Americans and Chinese will be challenged to avoid conflicts ... they are going to be required to function as one ... train in the Chinese language and Kung Fu martial arts ...
Breaking Medicine News(10 mins):Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 2Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 3Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 4Health News:National Access Cannabis Gives 300 Canadian Healthcare Professionals Access to Medical Cannabis Certificate Program 2Health News:Huntsville Medical Doctor Explains Why Physical Therapy May Not Treat Muscle Numbness Adequately 2Health News:Inside China: Americans Travel to Heartland of China to Live & Learn with Local Chinese 2Health News:Inside China: Americans Travel to Heartland of China to Live & Learn with Local Chinese 3
... cells from death in a model of stroke A ... of Sciences, China, has identified a way to preserve nerve cells ... caused by impaired delivery of oxygen to part of the brain ... known as ischemia). This leads to nerve cell death, although the ...
... diabetes who have high blood pressure, walk slowly or ... are significantly more likely to have weaker memory and ... problems, according to a new study published by the ... stood out from more than a dozen suspected to ...
... in the September Journal of Nuclear Medicine ... in the evaluation and treatment planning for a broad ... According to researchers, molecular imaging allows physicians to identify ... provide patients with personalized care. In addition, molecular imaging ...
... 2010) Faith based schools are on the rise ... religious values at odds with legislation on equality? Research ... and Leadership published by SAGE shows what happens when ... unfortunate consequences for gay students and staff. The ...
... cause of cancer deaths worldwide, and the prognosis is ... incidence of one type of lung cancer, adenocarcinoma, has ... the changes in tumor cell biology that result in ... mass of tissue) that have been completely surgically removed ...
... Implementation of staggered radiologist work shifts can expedite the ... to a study in the September issue of the ... ( www.jacr.org ). Radiology practice in the ... it has maximized coverage for imaging such as computed ...
Cached Medicine News:Health News:JCI online early table of contents: Sept. 1, 2010 2Health News:JCI online early table of contents: Sept. 1, 2010 3Health News:JCI online early table of contents: Sept. 1, 2010 4Health News:JCI online early table of contents: Sept. 1, 2010 5Health News:JCI online early table of contents: Sept. 1, 2010 6Health News:New study singles out factors linked to cognitive deficits in type 2 diabetes 2Health News:New study singles out factors linked to cognitive deficits in type 2 diabetes 3Health News:Personalized medicine: Molecular imaging predicts treatment success in many cancers 2Health News:Personalized medicine: Molecular imaging predicts treatment success in many cancers 3Health News:Keeping faith -- schools must balance ethos with equality 2Health News:Tumor budding identified as predictor for unfavorable outcome in lung cancer 2Health News:Staggered radiologist work shifts improve patient care, study suggests 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: